Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 2

Review

Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis

       
Total article views   HTML views PDF downloads Totals
7,139 Dovepress* 7,139+ 1,641 8,780
Totals 7,139 1,641 8,780
*Since 11 April 2008
+Since July 2016

View citations on Google Scholar